Lipid peroxidation and vitamin E status in gestational diabetes mellitus

Journal of Obstetrics and Gynaecology Research

Volumn 29, Issue 5, 2003, Pages 300-304

  Santra, Debjyoti ^a   Sawhney, Harjit ^a   Aggarwal, Neelam ^a   Majumdar, Siddarth ^a   Vasishta, Kala ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Tocopherol; Gestational diabetes mellitus; Lipid peroxide; Malondialdehyde thiobarbituric acid

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LIPID PEROXIDE; MALONALDEHYDE; THIOBARBITURIC ACID;

ADULT; ARTICLE; BLOOD SAMPLING; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; DELIVERY; DIABETIC DIET; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; LIPID BLOOD LEVEL; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MATERNAL MORBIDITY; ORAL GLUCOSE TOLERANCE TEST; PREECLAMPSIA; PREGNANCY; PREGNANCY DIABETES MELLITUS; PREMATURE LABOR; PRENATAL CARE; VENOUS BLOOD; VITAMIN BLOOD LEVEL;

ADULT; ALPHA-TOCOPHEROL; CHOLESTEROL, HDL; DIABETES, GESTATIONAL; FEMALE; HUMANS; INCIDENCE; LIPID PEROXIDATION; MALONDIALDEHYDE; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME;

EID: 0344876576     PISSN: 13418076     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1341-8076.2003.00127.x     Document Type: Article

References (22)

1. Metzer BE (eds). Summary and Recommendations of Third International Workshop - Conference on Gestational Diabetes Mellitus. Diabetes 1991; 40 (Suppl 2): 197-201.
2. Beischer NA, Oats JN, Henry OA, Sheedy MT, Walstab JE. Incidence and severity of gestational diabetes mellitus according to country of birth in women living in Australia. Diabetes 1991; 40 (Suppl 2): 35-38.
3. Moses R, Griffiths R, McPherson S. The incidence of gestational diabetes in the Illawara area of New South Wales. Aust NZ J Obstet Gynaecol 1994; 34: 425-427.
4. Kuhl E. Insulin secretion and insulin resistance in pregnancy and GDM. Implications for diagnosis and management. Diabetes 1991; 40 (Suppl 2): 18-24.
5. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes, 1991; 40: 405-412.
6. Lyons TJ. Oxidised low density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes? Diabetic Med 1991; 8: 411-419.
7. Warso MA, Nishigaki J, Haginara W, Tomato Y, Yagi I. Lipid peroxide levels and lipid serum content of serum lipoprotein fractions of pregnant subjects with or without preeclampsia. Clin Chim Acta 1981; 155: 155-161.
8. Jennings PE, Barnett AH. New approaches to the pathogenesis and treatment of diabetic microangiopathy. Diabet Med 1988; 5: 111-117.
9. Sivan E, Reece EA, Wu YK, Homco CJ, Polansky M, Borenstein M. Dietary vitamin E prophylaxis and diabetic embryopathy. Morphologic and biochemical analysis. Am J Obstet Gynecol 1996; 174: 793-799.
10. Bates JH, Young IS, Galway L, Traub AI, Hadden DR. Antioxidant status and lipid peroxidation in diabetic pregnancy. Br J Nutrition 1997; 78: 523-532.
11. Utley HG, Bernheim F, Hochstein P. Effect of sulfhydryl reagents on peroxidation in microsomes. Arch Biochem Biophys 1967; 118: 29-32.
12. Thurnham DI, Smith E, Flora PS. Concurrent lipid chromatographic assay of retinol, tocopherol, carotene, lycopene and eryptoxanthin in plasma, with tocopherol acetate as internal standard. Clin Chem 1988; 34: 377-381.
13. Nagasaka Y, Fuji S, Kaneko T. Effects of high glucose and sorbitol pathway on lipid peroxidation of erythrocytes. Horm Metab Res 1989; 21: 275-276.
14. Nishigaki L, Hagihara M, Tsunekawa H, Maseki M, Yagi K. Lipid peroxide levels of serum lipoprotein fraction of diabetic patients. Biochemistry 1981; 25: 373-378.
15. Haffner SM, Agil A, Mykkanen L, Stan MP, Jialal I. Plasma oxidizability in subjects with normal glucose tolerance, impaired glucose tolerance and NIDDM. Diabetes Care 1995; 18: 646-653.
16. Stringer MD, Gorog PG, Freeman A, Kakkai W. Lipid peroxides and atherosclerosis. Br Med J 1989; 298: 281-284.
17. Griesmacher A, Kindhauser M, Andeet SE et al. Enhanced serum levels of thiobarbituric acid reactive substances in diabetes mellitus. Am J Med 1995; 48: 469-475.
18. McLennan SV, Heffernen S, Wright L et al. Changes in hepatic glutathione metabolism in diabetes. Diabetes 1991; 8: 411-419.
19. Noberrasco G, Odetti P, Boeri D, Maiello M, Adezati L. Malondialdehyde (MDA) level in diabetic subjects. Relationship with blood glucose and glycosylated hemoglobin. Biomed Pharmacotherapeutics 1991; 45: 193-196.
20. Hiroyuki S, Shoichi A, Miwa I et al. Significance of glutathione-dependent antioxidant system in diabetes-induced embryonic malformations. Diabetes 1999; 48: 1138-1144.
21. Faure P, Corticelli P, Richard M et al. Lipid peroxidations and trace elements status in diabetic ketotic patients: Influence of insulin therapy. Clin Chem 1993: 39.
22. Alomare E, Vendemiale G, Chicco D, Procacci V, Cirelli F. Increased lipid peroxidation in type 2 poorly controlled diabetic patients. Diabetic Metab 1992; 18: 264-271.